Magnetoelastic galfenol as a stent material for wirelessly controlled degradation rates.


Journal

Journal of biomedical materials research. Part B, Applied biomaterials
ISSN: 1552-4981
Titre abrégé: J Biomed Mater Res B Appl Biomater
Pays: United States
ID NLM: 101234238

Informations de publication

Date de publication:
02 2019
Historique:
received: 18 08 2017
revised: 16 02 2018
accepted: 06 03 2018
pubmed: 25 3 2018
medline: 17 6 2020
entrez: 25 3 2018
Statut: ppublish

Résumé

The gold standard of care for coronary artery disease, a leading cause of death for in the world, is balloon angioplasty in conjunction with stent deployment. However, implantation injuries and long-term presence of foreign material often promotes significant luminal tissue growth, leading to a narrowing of the artery and severely restricted blood flow. A promising method to mitigate this process is the use of biodegradable metallic stents, but thus far they have either degraded too slowly (iron) or disappeared prematurely (magnesium). The present work investigates the use of a unique type of magnetic material, galfenol (iron-gallium), for postoperative wireless control of stent degradation rates. Due to its magnetoelastic property, galfenol experiences longitudinal micron-level elongations when exposed to applied magnetic fields, allowing generation of a microstirring effect that affect its degradation behavior. In vitro indirect cytotoxicity tests on primary rat aortic smooth muscle cells indicated that galfenol byproducts must be concentrated approximately seven times from collected 60 day degradation medium to cause ∼15% of death from all cells. Surface and cross-sectional characterization of the material indicate that galfenol (Fe

Identifiants

pubmed: 29573134
doi: 10.1002/jbm.b.34114
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

232-241

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Andrew DeRouin (A)

Biomedical Engineering, Michigan Technological University, Houghton, Michigan, 49931.

Roger Guillory (R)

Biomedical Engineering, Michigan Technological University, Houghton, Michigan, 49931.

Weilue He (W)

Biomedical Engineering, Michigan Technological University, Houghton, Michigan, 49931.

Megan Frost (M)

Biomedical Engineering, Michigan Technological University, Houghton, Michigan, 49931.

Jeremy Goldman (J)

Biomedical Engineering, Michigan Technological University, Houghton, Michigan, 49931.

Keat Ghee Ong (KG)

Biomedical Engineering, Michigan Technological University, Houghton, Michigan, 49931.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH